Neurocrine Bioscience buy Cantor Fitzgerald
Start price
16.09.24
/
50%
€110.65
Target price
16.09.25
€139.30
Performance (%)
-2.49%
Price
19.09.24
€107.90
Summary
This prediction is currently active. With a performance of -2.49%, the BUY prediction by Cantor_Fitzgerald is trending in the wrong direction. This prediction currently runs until 16.09.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Neurocrine Bioscience | -2.49% |
iShares Core DAX® | 2.291% |
iShares Nasdaq 100 | 1.336% |
iShares Nikkei 225® | 1.132% |
iShares S&P 500 | 1.272% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $155.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€116.40
29.08.24
29.08.24
€139.79
29.08.25
29.08.25
-7.30%
19.09.24
19.09.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€136.10
25.07.24
25.07.24
€142.68
25.07.25
25.07.25
-20.72%
19.09.24
19.09.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€129.55
10.04.24
10.04.24
€144.01
10.04.25
10.04.25
-16.71%
19.09.24
19.09.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.25
13.09.23
13.09.23
€126.70
13.09.24
13.09.24
-0.05%
14.09.24
14.09.24